Literature DB >> 24771791

Contribution of oxycodone and its metabolites to the analgesic effect.

G Mikus1, R Klimas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24771791     DOI： 10.1093/bja/aeu123

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN： 0007-0912            Impact factor:   9.166


× No keyword cloud information.
  4 in total

1.  Maturation of Oxycodone Pharmacokinetics in Neonates and Infants: a Population Pharmacokinetic Model of Three Clinical Trials.

Authors:  Pyry Välitalo; Merja Kokki; Veli-Pekka Ranta; Klaus T Olkkola; Andrew C Hooker; Hannu Kokki
Journal:  Pharm Res       Date:  2017-02-15       Impact factor: 4.200

2.  Peripherally restricted transthyretin-based delivery system for probes and therapeutics avoiding opioid-related side effects.

Authors:  Md Tariqul Haque Tuhin; Dengpan Liang; Fang Liu; Hala Aldawod; Toufiq Ul Amin; Joshua S Ho; Rasha Emara; Arjun D Patel; Melanie A Felmlee; Miki S Park; James A Uchizono; Mamoun M Alhamadsheh
Journal:  Nat Commun       Date:  2022-06-23       Impact factor: 17.694

3.  Chronic Low Dose Morphine Does Not Alter Two In Vitro BBB Models.

Authors:  Jamie Marino; Monique E Maubert; Jill M Lawrence; Brian Wigdahl; Michael R Nonnemacher
Journal:  Brain Sci       Date:  2022-07-06

4.  Post-mortem oxycodone blood concentrations of hospitalized cancer and surgery patients compared with fatal poisonings.

Authors:  Pirkko Kriikku; Eija Kalso; Ilkka Ojanperä
Journal:  Int J Legal Med       Date:  2022-09-06       Impact factor: 2.791
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.